New Implantable Tibial Nerve Stimulation Devices: Review of Published Clinical Results in Comparison to Established Neuromodulation Devices
Received 21 September 2019
Accepted for publication 26 November 2019
Published 23 December 2019 Volume 2019:11 Pages 351—357
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 2
Editor who approved publication: Dr Jan Colli
Justine Yamashiro,1 Werner de Riese,2 Cornelia de Riese3
1School of Medicine, Texas Tech University Health Science Center, Lubbock, TX, USA; 2Department of Urology, Texas Tech University Health Science Center, Lubbock, TX, USA; 3Department of Obstetrics and Gynecology, Texas Tech University Health Science Center, Lubbock, TX, USA
Correspondence: Werner de Riese
Department of Urology, Texas Tech University Health Science Center, 3601- 4th St., Stop 7260, Lubbock, TX 79430, USA
Tel +1-806 743 3972
Fax +1-806 743 3030
Purpose: The purpose of this review is to offer an update for medical providers practicing general urology and urogynecology in evolving and new promising technologies for neuromodulation in patients with OAB.
Patients and Methods: A focused literature search for the years 2015 through 2019 was conducted on PubMed/Medline for the terms: “new techniques” AND “neuromodulation” AND “tibial nerve stimulation” AND “overactive bladder”. We limited our search to publications in English, for the last five years and with patient follow-up of at least 3 months.
Results: Clinical success, safety based on adverse events, and quality of life improvement criteria were evaluated and compared to sacral nerve stimulation (SNS) devices and older, non-implantable percutaneous tibial nerve stimulation (PTNS) treatment devices. Considering the limited number of participants with up to 6 months follow-up data currently available, overall the clinical response rates suggest that the new implantable devices stimulating the tibial nerve have a promising clinical outlook, are less invasive upon implantation than SNS, less expensive, and less of a burden on patients compared to the older non-implantable PTNS devices.
Conclusion: Practicing urologists should be aware of this new treatment option when counseling their patients regarding treatment for OAB.
Keywords: overactive bladder, urgency, incontinence, frequency
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]